U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2001
187
Substance Class Protein
Created
by admin
on Mon Mar 31 22:40:08 GMT 2025
Edited
by admin
on Mon Mar 31 22:40:08 GMT 2025
Protein Type CYTOKINE
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
G8RGG88B68
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PEGINTERFERON ALFA-2B
EMA EPAR   INN   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
PEGINTRON
Preferred Name English
PEGYLATED-INTERFERON .ALFA. 2B (PEG-IFN)
Common Name English
Pegylated, recombinant interferon alfa-2b
Common Name English
peginterferon alfa-2b [INN]
Common Name English
MONOCARBOXYINTERFERON ALFA-2B, DIESTERS WITH POLYETHYLENE GLYCOL MONOMETHYL ETHER
Common Name English
PEGIFN ALFA-2B
Common Name English
PEGINTERFERON ALFA-2B [JAN]
Common Name English
PEGINTERFERON ALFA-2B [VANDF]
Common Name English
PEGINTERFERON ALFA-2B [MI]
Common Name English
PEGINTERFERON ALFA-2B [USAN]
Common Name English
PEGINTERFERON ALFA-2B [EMA EPAR]
Common Name English
PEGYLATED INTERFERON ALPHA 2B
Common Name English
PEGINTERFERON-ALFA-2B
Common Name English
SYLATRON
Brand Name English
Peginterferon alfa-2b [WHO-DD]
Common Name English
PEG-INTERFERON ALFA-2B
Common Name English
SYLATRON COMPONENT PEGINTERFERON ALFA-2B
Brand Name English
Classification Tree Code System Code
NDF-RT N0000175521
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
WHO-ATC L03AB60
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
FDA ORPHAN DRUG 249507
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
WHO-VATC QL03AB60
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
LIVERTOX 747
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
WHO-VATC QL03AB10
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
EMA ASSESSMENT REPORTS PEG-INTRON (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
EMA ASSESSMENT REPORTS VIRAFERON-PEG (AUTHORIZED: HEPATITS C, CHRONIC)
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
WHO-ATC L03AB10
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
NDF-RT N0000178331
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
Code System Code Type Description
MESH
C417083
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
INN
7909
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
SMS_ID
100000090296
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
RXCUI
253453
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY RxNorm
CAS
215647-85-1
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
WIKIPEDIA
PEGINTERFERON ALFA-2B
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
DRUG BANK
DB00022
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
EVMPD
SUB12549MIG
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
USAN
JJ-99
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
HSDB
8139
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
MERCK INDEX
m8446
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C1845
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
FDA UNII
G8RGG88B68
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
DRUG CENTRAL
5164
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201561
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
IUPHAR
7462
Created by admin on Mon Mar 31 22:40:08 GMT 2025 , Edited by admin on Mon Mar 31 22:40:08 GMT 2025
PRIMARY
From To
1_1 1_98
1_29 1_138
Related Record Type Details
INTERFERON ALPHA/BETA RECEPTOR 2
TARGET -> AGONIST
INTERFERON ALPHA/BETA RECEPTOR 1
TARGET -> AGONIST
Related Record Type Details
PEGINTERFERON ALFA-2B
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REPLACMENT HISTIDINE Amount: N3-(MPEG-12000)-HISTIDINE 90T0HF6NE5
AMINO ACID REPLACMENT LYSINE Amount: N6-(MPEG-12000)-LYSINE 3621075Y1N
AMINO ACID REPLACMENT [1_1] CYSTEINE Amount: N-(MPEG-12000)-CYSTEINE OL58LXQ32Z
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966